When Screening Guidelines Shift: Impacts on Healthcare Access & Use

This episode of Health Affairs This Week explores the real-world impacts of shifting clinical screening guidelines on healthcare access, utilization, and costs. Host Jeff Byers and guest Dr. Mike Pignone from Duke University School of Medicine discuss recent updates to cholesterol management guidelines by the ACC and AHA, emphasizing a more aggressive approach to lipid-lowering therapy—especially for people at low-to-intermediate cardiovascular risk (5-10% 10-year risk). The new guidelines recommend using the updated Prevent Risk Equations for better risk prediction, incorporating additional factors like LP(a) levels and coronary artery calcium (CAC) scoring to personalize treatment decisions. These changes aim to prevent more heart attacks and strokes, with statins highlighted as safe, effective, and low-cost. However, the episode also examines broader systemic challenges: as guidelines expand (e.g., lowering colon cancer screening age from 50 to 45), demand outpaces supply, particularly for colonoscopies, potentially undermining care for higher-risk patients. The discussion extends to hypertension, where lower blood pressure targets improve outcomes but strain under-resourced primary care systems. The overarching theme is that while new evidence supports earlier, more intensive prevention, the U.S. healthcare system’s structural limitations—especially in primary care funding and workforce capacity—threaten effective implementation. The episode concludes with a call for better data, communication, and health services research to guide equitable, cost-effective policy decisions in an era of expensive new therapies like PCSK9 inhibitors and GLP-1s.